The good performance of our shares, which in June recorded a daily weighted average price of over €13.3, allowed us to accelerate the exercise of the Gpi Warrants, bringing cash resources to the Group: €22.3 million were raised.
The funds will be dedicated to finance the Gruop’s ongoing growth process.
Scenario and benefits
A new french alliance to redefine cell therapies
The blood supply chain management software has obtained the Medical Device Marketing Authorization (MDMA)
We have deep roots, developed through 35 years of history. Competence, experience and passion guide our present and push us towards the future.
